Change Healthcare Inc. (NASDAQ:CHNG) CFO Fredrik J. Eliasson bought 40,000 shares of the firm’s stock in a transaction dated Thursday, August 15th. The shares were acquired at an average price of $13.73 per share, with a total value of $549,200.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

CHNG stock opened at $15.19 on Thursday. The company has a 50-day moving average price of $14.09. Change Healthcare Inc. has a 1-year low of $12.04 and a 1-year high of $15.50.

Change Healthcare (NASDAQ:CHNG) last released its quarterly earnings data on Tuesday, August 13th. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.18. The firm had revenue of $814.00 million during the quarter, compared to the consensus estimate of $795.66 million. The business’s quarterly revenue was down 1.1% compared to the same quarter last year. On average, research analysts anticipate that Change Healthcare Inc. will post 1.54 EPS for the current fiscal year.

Hedge funds have recently added to or reduced their stakes in the stock. Daiwa Securities Group Inc. purchased a new position in Change Healthcare in the second quarter valued at about $146,000. Jefferies Group LLC purchased a new position in Change Healthcare in the second quarter valued at about $219,000. KCL Capital L.P. purchased a new position in Change Healthcare in the second quarter valued at about $219,000. GSA Capital Partners LLP purchased a new position in Change Healthcare in the second quarter valued at about $248,000. Finally, SG Americas Securities LLC purchased a new position in Change Healthcare in the second quarter valued at about $337,000. Hedge funds and other institutional investors own 11.36% of the company’s stock.

Several research firms have recently weighed in on CHNG. Wells Fargo & Co began coverage on Change Healthcare in a research report on Monday, July 22nd. They set a “market perform” rating for the company. Guggenheim began coverage on Change Healthcare in a research report on Monday, July 22nd. They set a “buy” rating and a $17.00 target price for the company. Piper Jaffray Companies began coverage on Change Healthcare in a research report on Monday, July 22nd. They set an “overweight” rating and a $18.50 target price for the company. Svb Leerink began coverage on Change Healthcare in a research report on Monday, July 22nd. They set an “outperform” rating and a $20.00 target price for the company. Finally, Barclays started coverage on Change Healthcare in a research report on Monday, July 22nd. They set an “overweight” rating and a $18.00 target price for the company. One investment analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Change Healthcare presently has an average rating of “Buy” and a consensus target price of $19.04.

About Change Healthcare

Change Healthcare Inc, an independent healthcare technology platform, provides data and analytics-driven solutions to improve clinical, financial, and patient engagement outcomes in the United States healthcare system. It operates in three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services.

Read More: What is meant by holder of record?

Receive News & Ratings for Change Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Change Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.